New diabetic foot ulcer treatment on the horizon
The first shock wave device intended to treat diabetic foot ulcers has been approved. The Dermapace System is intended to be used on foot ulcers no larger than about the size of a soda can top.
Diabetes is the leading cause of lower limb amputations. New options for successfully treating and healing ulcer wounds may help prevent lower limb amputations.
An estimated 30.3 million people in the United States have been diagnosed with diabetes, according to the Centers for Disease Control and Prevention. Diabetes damages blood vessels and nerves, particularly in the feet, and can lead to severe infections that are difficult to treat. About 25 percent of people with diabetes will experience a foot ulcer in their lifetime. Amputation is sometimes necessary when circulation is so poor that a foot ulcer fails to heal or when treatment fails to stop the spread of an infection.
The Dermapace System is an external shock wave system that uses pulses of energy, similar to sound waves, to mechanically stimulate the wound. The device is intended for adult patients (22 years and older) with diabetic foot ulcers lasting for more than 30 days.
Click here to learn more about diabetes care and wound care at Hunt Regional.